Investing
262 Articles
Not many stocks are likely to double. Even well-run companies like Cisco Systems (NASDAQ:CSCO) are not likely to move 2x…
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…
Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…
Looking around the wreckage of some of the big cap companies it is not hard to find a few CEOs…
Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX)…
Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent…
It is always interesting seeing which groups and which stocks saw the biggest changes in short interest. This list doesn’t…
Several studies which showed that stents could cause blood clotting in the heart have done significant damage to the revenue…
According to Reuters, BHP Billiton (BHP) will not sell its petroleum division, as had been rumored, to finance a bid…
Boston Scientific (BSX) did it shareholders a terrible disservice buy buying Guidant in a bidding war with Johnson & Johnson.…
"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up…
(AMD) Advanced Micro Devices -$0.71 EPS vs -$0.62 est.(BSX) Boston Scientific $0.20 EPS vs $0.07 guidance.(CAT) Caterpillar $1.40 EPS vs…
The stent business continues to dog Boston Scientific (BSX) numbers. Several studies have shown that the devices can cause blood…
Accoriding to Reuters, Sony (SNE) will launch a cheaper version of its PS3 in the US in hopes of taking…
Workers in industries that are not doing well usually get laid off. But, it is not a good omen when…
Our top personal finance-related articles today. Your wallet will thank you later.